Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors

被引：3

作者：

Sasaki, Takahide ^{[1
]}

Nagase, Tsuyoshi ^{[1
]}

Takahashi, Toshiyuki ^{[1
]}

Nagumo, Akira ^{[1
]}

Shimamura, Ken ^{[1
]}

Miyamoto, Yasuhisa ^{[1
]}

Kitazawa, Hidefumi ^{[1
]}

Kanesaka, Maki ^{[1
]}

Yoshimoto, Ryo ^{[1
]}

Aragane, Katsumi ^{[1
]}

Tokita, Shigeru ^{[1
]}

Sato, Nagaaki ^{[1
,2
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Merck Res Labs, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

[2] Taisho Pharmaceut Co Ltd, Taisho Res Labs, Kita Ku, Saitama 3319530, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 15期

关键词：

Long chain fatty acid elongase 6 inhibitor; 2-Azabicyclo[2.2.2]octane; Anti-diabetic agent; Lipogenesis; ACYL-COA ELONGASE; ADIPOSE-TISSUE; GENE FAMILY; IDENTIFICATION; METABOLISM; CLONING;

D O I：

10.1016/j.bmc.2009.06.042

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of novel 2-azabicyclo[2.2.2]octane derivatives was synthesized and evaluated as long chain fatty acid elongase 6 (ELOVL6) inhibitors. Screening of our corporate chemical collections against ELOVL6 resulted in the identification of lead 1. Exploratory chemistry efforts were applied to lead 1 to identify the orally available, potent, and selective ELOVL6 inhibitor 28a. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5639 / 5647

页数：9

共 24 条

[21] Design, synthesis and biological evaluation of novel 1-methyl-3-oxo-2,3,5,6,7,8-hexahydroisoquinolins as potential EZH2 inhibitors
Zhang, Lidan
Song, Xuejiao
Wang, Ningyu
Zhao, Lifeng
Feng, Qiang
You, Xinyu
Peng, Cuiting
Gao, Tiantao
Xiong, Menghua
He, Bing
Gao, Chao
Luo, Yong
Xu, Ying
Zhang, Qiyi
Yu, Luoting
RSC ADVANCES, 2015, 5 (33) : 25967 - 25978
[22] 5,5-Dimethyl-3-(5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione, a Potent Inhibitor for Mammalian Elongase of Long-Chain Fatty Acids Family 6: Examination of Its Potential Utility as a Pharmacological Tool
Shimamura, Ken
Kitazawa, Hidefumi
Miyamoto, Yasuhisa
Kanesaka, Maki
Nagumo, Akira
Yoshimoto, Ryo
Aragane, Katsumi
Morita, Naomi
Ohe, Tomoyuki
Takahashi, Toshiyuki
Nagase, Tsuyoshi
Sato, Nagaaki
Tokita, Shigeru
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (01) : 249 - 256
[23] Novel 6, 7-disubstituted 7H-purine analogues as potential EGFR/HER2 dual kinase inhibitors overcome lapatinib resistance: Design, synthesis, in-vitro and in-vivo evaluation
Bayya, Chandraprakash
Dokala, Appaji
Manda, Sarangapani
RESULTS IN CHEMISTRY, 2022, 4
[24] Synthesis and evaluation of novel stearoyl-CoA desaturase 1 inhibitors: 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-3,4-dihydrospiro[chromene-2,4′-piperidine] analogs
Uto, Yoshikazu
Ueno, Yuko
Kiyotsuka, Yohei
Miyazawa, Yuriko
Kurata, Hitoshi
Ogata, Tsuneaki
Yamada, Makiko
Deguchi, Tsuneo
Konishi, Masahiro
Takagi, Toshiyuki
Wakimoto, Satoko
Ohsumi, Jun
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) : 4788 - 4796

← 1 2 3 →